Ranevetmab Biosimilar - Research Grade

Human

NGF

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01138

Blue ice

Nerve growth factor (NGF) is a neurotrophin central to pain signaling and sensory-neuron biology. This recombinant human IgG1 kappa antibody is an unconjugated, non-therapeutic analog of ranevetmab, generated in CHO cells against human NGF. For research use only, it is formulated to low endotoxin for in vivo compatibility and supplied in scalable milligram (mg) to gram (g) quantities for high-throughput laboratories. It serves as a dependable reagent for neurotrophin-neutralization assays, pain-signaling studies, functional characterization, and preclinical models of chronic pain. Stringent purification supports robust, repeatable readouts in resource-intensive studies.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks